Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Sunshine Biopharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Sunshine Biopharma, Inc. Earnings Date And Information
Sunshine Biopharma, Inc. last posted its earnings results on Tuesday, November 5th, 2024. The company reported $-0.94 earnings per share for the quarter, missing analysts' consensus estimates of $9 by $9.94. The company had revenue of 9.59 M for the quarter and had revenue of 34.87 M for the year. Sunshine Biopharma, Inc. has generated $-7 earnings per share over the last year ($-7.32 diluted earnings per share) and currently has a price-to-earnings ratio of -0.12. Sunshine Biopharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 19th, 2025 based on prior year's report dates.
Sunshine Biopharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/01/2025 | Q4 2024 | N/A | $0.00 | N/A | N/A | $9.59 M |
| 11/05/2024 | Q3 2024 | $9.00 | -$0.94 | -9.94 | $11.80 M | $8.44 M |
| 08/20/2024 | Q2 2024 | N/A | -$9.94 | N/A | $9.00 M | $9.30 M |
| 05/20/2024 | Q1 2024 | -$1.04 | -$40.04 | -39 | N/A | $7.54 M |
| 03/28/2024 | Q4 2023 | -$3.00 | -$104.69 | -101.69 | N/A | $7.68 M |
| 11/13/2023 | Q3 2023 | -$0.06 | -$50.72 | -50.66 | $6.00 M | $5.96 M |
| 08/10/2023 | Q2 2023 | N/A | -$0.71 | N/A | $5.00 M | $5.56 M |
| 05/10/2023 | Q1 2023 | N/A | -$154.61 | N/A | N/A | $4.89 M |
| 12/31/2022 | Q4 2022 | N/A | -$1.05 | N/A | N/A | $3.94 M |
| 11/07/2022 | Q3 2022 | N/A | -$7.71 | N/A | N/A | $132,808 |
| 08/03/2022 | Q2 2022 | N/A | -$2.41 | N/A | N/A | $150,307 |
| 05/06/2022 | Q1 2022 | N/A | -$7.82 | N/A | N/A | $122,645 |
| 03/21/2022 | Q4 2021 | N/A | $0.65 | N/A | N/A | $85,118 |
| 11/09/2021 | Q3 2021 | N/A | -$26.48 | N/A | N/A | $50,376 |
| 08/09/2021 | Q2 2021 | N/A | -$20.06 | N/A | N/A | $52,874 |
| 05/11/2021 | Q1 2021 | N/A | -$46.99 | N/A | N/A | $40,058 |
| 03/30/2021 | Q4 2020 | N/A | -$6.43 | N/A | N/A | $28,013 |
| 11/10/2020 | Q3 2020 | N/A | -$4.15 | N/A | N/A | $17,150 |
| 08/19/2020 | Q2 2020 | N/A | -$3.48 | N/A | N/A | $15,145 |
| 05/18/2020 | Q1 2020 | N/A | -$0.50 | N/A | N/A | $11,102 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Sunshine Biopharma, Inc. Earnings: FAQ's
Sunshine Biopharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 19th, 2025 based offlast year's report dates.
The conference call for Sunshine Biopharma, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Sunshine Biopharma, Inc.'s latest earnings report can be read online.
Sunshine Biopharma, Inc. (:SBFM) has a recorded annual revenue of $34.87 M.
Sunshine Biopharma, Inc. (:SBFM) has a recorded net income of $-5,134,116.Sunshine Biopharma, Inc. has generated $-7.32 earnings per share over the last four quarters.
Sunshine Biopharma, Inc. (:SBFM) has a price-to-earnings ratio of -0.12 and price/earnings-to-growth ratio is -0.